10 Best “Strong Buy” Stocks — CBPO HOLX EBIX and more

Portfolio Grader gives these picks top marks in several categories

By Portfolio Grader

http://invstplc.com/1Yc3Rbe

This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.

China Biologic Products, Inc. (CBPO) has risen 48.7% since the first of the year. China Biologic Products is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. For more information, get Portfolio Grader’s complete analysis of CBPO stock.

Shares of Hologic, Inc. (HOLX) have risen 49.1% since January 1. Hologic develops, manufactures, and markets x-ray systems. For more information, get Portfolio Grader’s complete analysis of HOLX stock.

Since the first of the year, the price of Ebix, Inc. (EBIX) has swelled 61.7%. Ebix provides a series of application software products for the insurance industry, including carrier systems and agency systems. For more information, get Portfolio Grader’s complete analysis of EBIX stock.

Since January 1, JetBlue Airways Corporation (JBLU) has shot up 66.9%. JetBlue Airways provides nonstop passenger flight service through its Airbus A320 aircraft. For more information, get Portfolio Grader’s complete analysis of JBLU stock.

The price of Stamps.com (STMP) has seen a 70.6% boost since the first of the year. Stamps.com is an Internet-based company that allows customers to send mail. For more information, get Portfolio Grader’s complete analysis of STMP stock.

Since January 1, Ellie Mae, Inc. (ELLI) has jumped 78.8%. Ellie Mae provides business automation software for the mortgage industry in the United States. For more information, get Portfolio Grader’s complete analysis of ELLI stock.

The price of Sucampo Pharmaceuticals, Inc. Class A (SCMP) is up 86% since the first of the year. Sucampo Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. For more information, get Portfolio Grader’s complete analysis of SCMP stock.

Since January 1, Skechers U.S.A., Inc. Class A (SKX) has climbed 139.6%. Skechers USA designs, makes, markets and distributes footwear. For more information, get Portfolio Grader’s complete analysis of SKX stock.

Since the first of the year, shares of ABIOMED, Inc. (ABMD) have soared 160.5%. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. For more information, get Portfolio Grader’s complete analysis of ABMD stock.

Since January 1, the price of Chimera Investment Corporation (CIM) has grown 305.9%. Chimera Investment is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The stock’s trailing PE Ratio is 5.00. For more information, get Portfolio Grader’s complete analysis of CIM stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/09/10-best-strong-buy-stocks-cbpo-holx-ebix-and-more-cbpo-holx-ebix/.

©2018 InvestorPlace Media, LLC